
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.890 | 2.140 | 0.250 |
Shares | 98.110 | 98.110 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.997 | 17.149 |
Price to Book | 4.598 | 3.717 |
Price to Sales | 5.022 | 5.028 |
Price to Cash Flow | 12.504 | 14.632 |
Dividend Yield | 1.048 | 0.520 |
5 Years Earnings Growth | 3.929 | 8.646 |
Number of long holdings: 83
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 10.18 | 114.76 | +0.46% | |
Amgen | US0311621009 | 9.28 | 301.37 | -0.72% | |
Vertex | US92532F1003 | 8.64 | 469.16 | +0.16% | |
AstraZeneca ADR | US0463531089 | 5.68 | 76.59 | +3.53% | |
Alnylam | US02043Q1076 | 4.59 | 339.80 | +2.80% | |
Regeneron Pharma | US75886F1075 | 4.20 | 554.80 | -0.60% | |
Insmed | US4576693075 | 2.84 | 105.18 | +0.17% | |
argenx ADR | US04016X1019 | 2.75 | 598.89 | +0.02% | |
Sanofi ADR | US80105N1054 | 2.51 | 49.25 | -0.20% | |
Summit Therapeutics PLC | US86627T1088 | 2.18 | 26.660 | -0.30% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DE000A2DU1Y2 | 16.31M | -0.15 | -3.20 | 1.46 | ||
Kapital Plus P EUR | 7.71M | 0.91 | -2.17 | 2.49 | ||
Kapital Plus P2 EUR | 1.82M | 2.45 | 0.39 | 2.48 | ||
Kapital Plus I EUR | 97.01M | 2.43 | 0.24 | 2.33 | ||
Kapital Plus A EUR | 2.43B | 0.26 | 3.45 | 1.73 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review